To examine the effects of bowel management on urinary incontinence in patients with spina bifida associated with overactive bladder (OAB) and detrusor sphincter dyssynergia (DSD).
Materials and Methods
The research was carried out during the period 2014-2017. A total of 35 patients (group 1) were administered bowel management combined with anticholinergic medication therapy and clean intermittent catheterization (CIC) and 35 patients (group 2) were treated only with anticholinergic medication therapy and CIC. Bowel management included daily enema, laxative application and a special diet, with the aim of treating constipation, evaluated according to the Roma III criteria and echosonographically determined transversal rectal diameter. The effects of the administered bowel management on urinary incontinence were assessed according to the mean dry interval between two CICs for all patients. All patients were followed up for 1 year, during which data were prospectively collected.
Results
There was no statistically significant difference with regard to age, gender and baseline clinical features between the two groups. In group 1, the mean AE SD dry interval between two CICs was 150.0 AE 36.4 min, and group 2 it was 101.3 AE 51.6 min. There was a significant difference in urinary incontinence, i.e. in the mean dry interval, between the two groups (P < 0.001).
Introduction
Spina bifida is a complex congenital neuroembryological disorder stemming from incomplete closure of the neural tube, affecting multiple organ systems including bladder and bowel function [1] .
Urinary incontinence has a far-reaching impact on individuals with spina bifida and is a significant contributor to their quality of life, influencing their self-esteem and ability to successfully navigate the social sphere. Achieving continence is therefore a primary goal with respect to improving the quality of life of patients with spina bifida [2] . Most children with a history of spina bifida also have a high frequency of neurogenic bowel problems (75-92%), including constipation [3] .
The influence of constipation on lower urinary tract function and urinary incontinence in children without other urological abnormalities has long been known [4, 5] ; however, the current literature features very few papers that study the correlation between bowel dysfunction and bladder dysfunction in people with spina bifida, and their results differ. The aim of the present study, therefore, was to study the effects of bowel management on urinary incontinence in people with spina bifida who have overactive bladder (OAB) and detrusor sphincter dyssynergia (DSD).
Materials and Methods

Study Population
In the Urology Department of the University Children's Hospital in Belgrade, a prospective cohort study was carried out from 2014 to 2017, in which patients with spina bifida were observed. Patients with spina bifida in whom constipation was confirmed based on the Roma III criteria and echosonographic transversal rectal diameter <3 cm [6] were included. The presence of OAB and DSD was also an inclusion criterion. OAB was defined as echosonographically determined bladder wall thickness >5 mm [7, 8] and voiding cysto-urethrography (VCUG) findings of bladder wall irregularity, elongation of bladder shape, filling of the posterior urethra and external urethral sphincter inner diameter <3 mm [9, 10] . DSD was confirmed based on uroflowmetry with patch electromyography. Patients in whom, during bladder filling, VCUG verified the existence of a wide open and funnelshaped bladder neck, were excluded from the study for suspected incompetent bladder outlet [11] . To exclude such patients we also carried out needle electromyography of the external urethral sphincter in all those with whom we were able to cooperate adequately. Patients with confirmed external urethral sphincter atony were also excluded from the study [12] . The remaining exclusion criterion was previous bowel management ≤12 months before commencement of the present study.
The inclusion criteria were met by 77 patients, for all of whom anticholinergic medication, CIC and bowel management therapy were recommended; however, only 35 patients accepted the full treatment. A total of 35 patients agreed to undergo anticholinergic and CIC treatment, but without bowel management. These patients and their parents were not motivated to administer bowel management in a domestic environment owing to the complicated nature of the procedure itself despite being provided with clear instructions related to the treatment itself, as well as an explanation of its advantages. Accordingly, two groups were formed with 35 consecutive patients each. The remaining seven patients accepted other treatment methods and were excluded from the further phases of the study.
Study Protocol
The study population included 35 consecutive patients in whom bowel management combined with anticholinergic medication therapy and CIC was administered (group 1) and 35 consecutive patients who were only treated with anticholinergic medication therapy and CIC (group 2). Patients were followed up for 1 year.
Before therapy commenced, an assessment of urinary incontinence in all patients in both groups was carried out by recording the mean dry interval. Before dry interval assessment, the absence of urinary infection was confirmed in all patients based on sterile urine culture results. Continence diaries were kept and assessment of mean dry interval was carried out by the patients' parents, which was done by checking diaper soaking during 48 h (checks were carried out every 15 min for a total of eight intervals, each interval lasting 3 h, with no assessment carried out during the nighttime), after which the mean dry interval was determined.
After the evaluation, all patients were prescribed anticholinergic medication therapy (Oxybutynin) 0.2 mg/kg/ dose three times daily.
In all patients CIC was also administered every 3 h through a continent vesicostomy, or through a native urethra with the aid of a nelaton catheter; the catheterization was either carried out by the patients' parents, or independently by the older patients.
For all patients in group 1, the therapy also included bowel management, which encompassed procedures aimed at treating constipation. The diet regimen was altered, a mean fluid intake of 1 500 mL/m 2 body surface was recommended equally divided during the day in four to six portions, as well as the daily application of 15-20 g of dietetic fibre. All the patients were prescribed retrograde transanal enemas of 10-20 mL/kg/day, a maximum of 1 L physiological solution with an addition of glycerine, and if necessary, to stimulate bowel movement, digital rectal stimulation and suppositories (Bisacodyl) were applied. In the first 3 months, the enemas were prescribed daily, then every second day for 3 months, and thereafter according to circumstances, with the reapplication of daily enemas in case of inadequate response. All the patients were also prescribed laxatives (Polyethylene glycol) with additional electrolytes 0.7 g/kg/day, prescribed daily in the first 3 months, then every third day for 3 months, and thereafter according to circumstances, with reapplication of daily laxatives in case of inadequate response. One patient had Malone continent appendicostomy, through which daily antegrade enema of the order 10-20 mL/kg/day was carried out, with a maximum of 1 litre of physiological solution with an addition of glycerine.
Regular follow-ups to evaluate the treatment protocol, i.e. assessing treatment results in all patients, were carried out every 3 months. During every visit the mean dry intervals between two CICs, as well as constipation frequency based on criteria identical to those used for the pre-treatment periods, were analysed. During the follow-up period, the patients were found to have a high level of adherence to the treatment protocol, except for one patient in group 1 and two patients in group 2 who had follow-up of <1 year because they discontinued therapy before this point. In both groups, the patients and parents were supported by a psychologist with the aim of achieving as close as possible adherence to treatment.
At 1 year follow-up, the effects of bowel management in treating constipation were assessed by comparing the results in this group with those of group 2 in whom bowel management was not administered. For both groups the mean dry interval between two CICs was also determined in order to assess the effects of two therapies on severity of urinary incontinence.
Side Effects
During each visit we checked for the following possible side effects of bowel management: abdominal pain; sweating; chills; pronounced general discomfort; dizziness; nausea; headache; facial flushing; anorectal pain; rectal burn; stricture and inflammation (chemical colitis); diarrhoea; and bowel perforation with serious and potentially fatal complications. None of these side effects was observed.
Statistical Analysis
Descriptive statistics were calculated for the baseline demographic and clinical features, as well as treatment outcomes. Continuous variables are presented as means and SD values and categorical variables are presented as numbers and percentages. Differences between groups with corresponding 95% CIs were also calculated. Baseline differences between groups were analysed using Student's t-test for continuous variables, and the Pearson chi-squared test for categorical variables. Repeated-measures ANOVA with group interaction were used to test changes in mean dry intervals in the two groups. Changes in examined variables in each study group are presented by line graph (Fig. 1) , where the lines represent summary measures (mean) and shaded areas represent the 95% CIs [13] . The level of significance was set at 0.05. Statistical analysis was performed using the SPSS 21 (IBM, Chicago, IL, USA) 2012 package.
Results
In group 1, 35 patients were administered bowel management combined with anticholinergic medication therapy and CIC. Their mean (range) age was 10.2 AE 4.0 (4-22) years, and 48.6% were male and 51.4% female. Group 2 consisted of 35 patients who were treated only with anticholinergic medication therapy and CIC. The mean (range) age of the patients in group 2 was 9.8 AE 5.2 (4-22) years, and 37.1% of these patients were male and 62.9% female. There was no significant difference between the two groups with regard to age or sex (P > 0.05). Table 1 shows the baseline demographic and clinical features of the study population, stratified by group, including type and localization of spina bifida, associated hydrocephalus, administered VCUG, presence of VUR, VUR treatment method, administration of antibiotic prophylaxis during the observation period, average number of urinary infections before treatment commenced, other urological surgical interventions (continent vesicostomy), any treatment administered earlier, as well as the administration of orthopaedic surgical interventions and ability to walk unaided. There was no significant difference between the groups with regard to any of these variables (P > 0.05).
At baseline there was no statistically relevant difference in constipation level between the groups (P > 0.05; Table 2 ). After 1 year of treatment in group 1, 31 patients (88.57%) no longer had constipation, while in group 2, 35 patients (100%) still had constipation ( Table 2 ). The patients in group 1, who received bowel management, had significantly better control of constipation, which was reflected in daily bowel evacuations and echosonographically confirmed transversal rectal diameter <3 cm (P < 0.001).
The mean dry intervals were not significantly different between the groups before treatment (P = 0.730; Table 2 ). After 1 year of treatment, the mean dry interval between two CICs in group 1 was 150.0 AE 36.4 min, whereas in group 2 it was 101.3 AE 51.6 min ( Table 2 ). The patients with bowel management combined with anticholinergic medication therapy and CIC (group 1) had a significantly lower degree of 
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© 2018 The Authors BJU International © 2018 BJU International urinary incontinence, which was reflected in a longer mean dry interval between two CICs (P < 0.001).
Bowel management successfully treated the constipation, but also considerably alleviated symptoms of urinary incontinence in patients with spina bifida. Repeated-measures ANOVA indicated a substantial statistical interaction between the groups (P < 0.001); that is, the mean dry interval considerably increased in the group of patients who received bowel management combined with anticholinergic medication therapy and CIC (Figs 1 and 2 ).
Discussion
Urinary incontinence in children with spina bifida continues to challenge the ingenuity and skill of paediatric urologists around the world [14] . Incontinence is not life-threatening, IV and V degree, surgically treated with execution of ureteroneocystostomy.
‡ From distal end of ureter after executed ureteroneocystostomy. § Administered during the observation period (one-third of therapy dose every evening before bed).
¶ Bowel management discontinued ≤12 months before the study began. © 2018 The Authors BJU International © 2018 BJU International 121 but can cause a high level of emotional distress for the child and their family. Effective management of these children should be a priority for all of us, since the reward, in the form of a happy, sociable child, is so worthwhile [15] .
The introduction of CIC in 1972 [16] , often combined with anticholinergic medication to decrease detrusor activity, has revolutionized the management of DSD, and was an important advance in the management of patients with spina bifida [16] . CIC provides regular and complete bladder emptying and, therefore, can prevent increased filling pressure in poorly compliant bladders or overflow incontinence in poorly contractile bladders. Anticholinergic medication, used in concert with CIC, can further decrease bladder pressure and improve incontinence through its inhibitory effects on the detrusor [17] .
If this approach fails or is not tolerated by the patient, second-line options include an array of different therapy protocols [18] . Because aggressive surgical procedures, which can lead to numerous complications, have not proven efficient enough, the emphasis in treating incontinence is now laid primarily on less aggressive techniques [19] . Accordingly, the aim of the present study was to test a non-invasive therapy technique (bowel management), with the hypothesis that successful constipation treatment would alleviate the symptoms of urinary incontinence in patients with spina bifida.
The influence of constipation on lower urinary tract function and urinary incontinence in children without other urological abnormalities has long been known [4, 5] . Loening-Baucke [5] managed to successfully treat daytime urinary incontinence in 89% of patients, and to solve the problem of nocturnal enuresis in 63% of patients only through successful treatment of constipation without applying other types of treatment in children who had no other urological abnormalities [5] .
The results of the present study clearly indicate that successful treatment of constipation noticeably alleviates urinary incontinence symptoms in patients with spina bifida with OAB and DSD, although the mechanism for this is unclear. The effect was confirmed by the longer mean dry interval between two CICs in patients who received bowel management compared with patients who did not.
There are numerous theories to explain the correlation between constipation and lower urinary tract dysfunction, including the anatomical proximity of the bladder and urethra to the rectum, and their common embryological origin and similar innervation [20] . Another explanation could be that the retention of a larger quantity of fecal matter in the rectum and sigmoid colon causes compression of the bladder, including its neck, and thus considerably influences bladder capacity and contractility (through stimulating an increase in bladder contractility and decreasing its functional capacity) [21] , or can completely block bladder activity [22] . Another explanation put forward, however, is the strong ties between the bladder and bowel in the central nervous system [23] .
The current literature includes very few studies on the correlation between bowel and bladder dysfunction in patients with spina bifida, and their results differ. One of the rare studies is a paper by De Kort et al. [24] , who did not find any statistically relevant changes in urodynamic variables after administering bowel management in patients with spina bifida. There were no significant changes overall in bladder capacity, leak point pressure, bladder compliance or bladder instability [24] . In view of the fact that the patients in the present study benefited from bowel management, and that we did not run urodynamic tests, it is difficult to determine to what extent and by which exact mechanism bowel management influenced the alleviation of symptoms of urinary incontinence in our patients, but it is certain that we should continue administering it in the future. We will seek answers to these questions by conducting urodynamic testing in a future study.
Similarly to the present study, the study by Cameron et al. [25] , including patients with neurogenic bladder, showed that bladder symptoms of incontinence and LUTS correlated directly with bowel symptom scores, signifying how important it is for a treating urologist to address bowel dysfunction along with urinary issues.
Bowel management is a challenging problem in children and adults with spina bifida. Liptak et al. [26] concluded that good results were obtained for constipation and incontinence in patients with good adherence to the therapy. Low adherence, i.e. difficulties in accepting and adequately 
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© 2018 The Authors BJU International © 2018 BJU International administering bowel management both by the parents and the children, can be a reason for treatment failure, and may explain divergent results in earlier studies. Challenges with regard to treatment adherence were confirmed in the present study, in which 35 patients immediately refused the offered bowel management. There were also patients in both groups (group 1, four patients, group 2, three patients) who had previously received and arbitrarily discontinued bowel management.
Patient and caregiver motivation is vital in achieving treatment success, which is why we included psychologists in the present study who could support the patients and their parents in adhering to the treatment. Owing to good treatment adherence, constipation was successfully resolved in the group that received bowel management and the symptoms of urinary incontinence were considerably alleviated.
Limitations of the present study include the small number of studied patients, the fact that the study was not randomized, and the fact that we did not carry out urodynamic testing. These limitations should be taken into consideration before further research is conducted. Despite its limitations, the results of the present study should encourage further randomized studies that include a greater number of patients and conduct urodynamic testing.
In conclusion, regular administration of bowel management successfully treated constipation, but also considerably increased the mean dry interval in our patients and thus greatly alleviated symptoms of urinary incontinence. Bowel management should therefore form an integral part of treatment in patients with spina bifida with OAB and DSD.
